Skip to main content
SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine.
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.
Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis.